Dr. Harry W. Sell Jr., MD

Dr. Sell practices at UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Sell's NPI, 1619949799, was assigned on February 3, 2006. Dr. Sell graduated from Temple University School of Medicine in 1980. Dr. Sell holds Pennsylvania license MD026375E.

Dr. Sell's primary practice is UPMC Mercy, at 1400 Locust Street, Pittsburgh, PA 15219 in Allegheny County. The practice phone is (412) 232-8111.

Dr. Sell's primary practice is UPMC Mercy in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Sell is also affiliated with UPMC Presbyterian. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Sell to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sell practices, 3 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Sell's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Sell is licensed in Pennsylvania.

CMS data shows 113 Medicare services from Dr. Sell across 5 procedure codes in 2024, for 113 Medicare patients. Medicare paid $8,810 for them.

CMS counts 113 Medicare patients who saw Dr. Sell in 2024. The largest group is 65 to 74, with 60 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.58, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sell's median patient age at 66, with 44% women.

In 2024, Dr. Sell wrote 112 Medicare Part D claims for 59 patients. 96% of them were for generic drugs. CMS names the drug for 23 of them, across 1 drug with 11 or more claims each, at $384 in total drug cost. In 2023, CMS named 42 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Sell for performance year 2024, reported as part of a group. Dr. Sell accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 18 procedures of hernia repair - groin (open) by Dr. Sell, more than 96% of the clinicians it reports for that procedure.

Colonoscopy: 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 5 papers to Dr. Sell, published from 2015 to 2022. The most frequent topics are Tomography, X-Ray Computed. Dr. Sell's most frequent co-authors are Anil K. Dasyam, Paul J. Rusilko, DO and Cheryl K. Six.

CMS Open Payments shows 200 general payments to Dr. Sell from 19 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 55% of the total. TELA Bio, Inc. paid the most, $5,324.

Dr. Sell graduated from Temple University School of Medicine in 1980.